Friday - August 1, 2025
UTSW Research: Anaphylaxis Hospital Stays, LDL-lowering Drug, and More
July 22, 2025
DALLAS, Texas, July 22 (TNSjou) -- The University of Texas Southwestern Medical Center issued the following news release:

* * *

UTSW Research: Anaphylaxis hospital stays, LDL-lowering drug, and more

Studies look at children's ED visits, a new class of medication, and a treatment for urothelial carcinoma

Shorter hospital stays safe for most children with anaphylaxis

*

Up to 5% of the U.S. population has experienced . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products